ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 200 filers reported holding ARGENX SE in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $182,962,563 | -8.5% | 372,155 | -27.5% | 0.80% | -6.2% |
| Q2 2023 | $200,031,261 | -2.2% | 513,256 | -6.5% | 0.85% | -15.1% |
| Q1 2023 | $204,554,617 | +5.8% | 549,022 | +7.5% | 1.01% | -14.7% |
| Q4 2022 | $193,427,567 | +6.8% | 510,592 | -0.5% | 1.18% | +2.0% |
| Q3 2022 | $181,133,000 | -8.6% | 513,052 | -1.9% | 1.16% | -3.3% |
| Q2 2022 | $198,086,000 | +18.7% | 522,821 | -1.2% | 1.20% | +37.5% |
| Q1 2022 | $166,870,000 | +150.5% | 529,224 | +178.2% | 0.87% | +150.7% |
| Q4 2021 | $66,616,000 | – | 190,229 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |